Search Results - "Hofner, K"

A placebo‐controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence by MADERSBACHER, H, HALASKA, M, VOIGT, R, ALLOUSSI, S, HÖFNER, K

“…Objective  To assess the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence in a randomized, double‐blind…”
Get full text

Improvements in benign prostatic hyperplasia‐specific quality of life with dutasteride, the novel dual 5α‐reductase inhibitor by O'Leary, M.P., Roehrborn, C., Andriole, G., Nickel, C., Boyle, P., Höfner, K.

“…OBJECTIVES To examine the effect of the dual‐action 5α−reductase inhibitor dutasteride on benign prostatic hyperplasia (BPH)‐specific health status, as…”
Get full text

Standardization of terminology of lower urinary tract function: Pressure-flow studies of voiding, urethral resistance, and urethral obstruction by Griffiths, Derek, Höfner, Klaus, van Mastrigt, Ron, Rollema, Harm Jan, Spångberg, Anders, Gleason, Donald

Get full text

Automation in urodynamics by Höfner, K

“…The information concerning bladder function during voiding and the size of the outlet resistance is found in relation to detrusor pressure and urinary flow…”
Get more information

Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability by Halaska, M, Ralph, G, Wiedemann, A, Primus, G, Ballering-Brühl, B, Höfner, K, Jonas, U

“…Our objectives were to ascertain the tolerability and efficacy of trospium chloride in doses of 20 mg twice daily for long-term therapy (52 weeks) in patients…”
Get full text

Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction by Höfner, K, Claes, H, De Reijke, T M, Folkestad, B, Speakman, M J

“…To evaluate the effect of tamsulosin, 0.4 mg once daily, on sexual function in comparison with placebo and alfuzosin, 2.5 mg three times daily, in patients…”
Get more information

Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia by Höfner, K., Burkart, M., Jacob, G., Jonas, U.

“…Objectives To investigate the symptomatic and quality of life (QoL) response to treatment with tolterodine extended release (ER) in subgroups of male patients…”
Get full text

Intratesticular self-injection of testgasoline by Hagemann, J H, Machtens, S A, Stief, C G, Höfner, K, Jonas, U

Get more information

The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study by Tubaro, A, Carter, S S, de la Rosette, J, Höfner, K, Trucchi, A, Ogden, C, Miano, L, Valenti, M, Jonas, U, Debruyne, F

“…A total of 100 patients treated with a single session of microwave thermotherapy at 4 European centers was stratified according to 2 different types of…”
Get more information

Bladder outlet obstruction by ABRAMS, P, HÖFNER, K

Get full text

The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study by Haillot, O, Fraga, A, Maciukiewicz, P, Pushkar, D, Tammela, T, Höfner, K, Chantada, V, Gagnier, P, Morrill, B

“…CombAT (Combination of Avodart and Tamsulosin) was a randomised, double-blind study in men ( n =4844) aged ⩾50 years with a clinical diagnosis of BPH. Patients…”
Get full text

Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia by HÖFNER, K, BURKART, M, JACOB, G, JONAS, U

“…Patients with presumed non-obstructive BPH (Q (max )>or= 15 ml/s) treated with tolterodine ER 4 mg/day for OAB symptoms, alone or added to unsuccessful…”
Get full text

Male lower urinary tract symptoms and related health care seeking in Germany by Berges, R R, Pientka, L, Höfner, K, Senge, T, Jonas, U

“…To investigate the prevalence of lower urinary tract symptoms (LUTS) and LUTS- related health care issues in the male population between the ages of 50 and 80…”
Get more information

Does bone anchor fixation improve the outcome of percutaneous bladder neck suspension in female stress urinary incontinence? by Schultheiss, D, Höfner, K, Oelke, M, Grünewald, V, Jonas, U

“…Objective  To evaluate the outcome of a new modification of percutaneous needle suspension, using a bone anchor system for fixing the suture at the pubic bone,…”
Get full text

Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia by Höfner, K, Oelke, M, Machtens, S, Grünewald, V

“…Trospium chloride (TCL), a quaternary ammonium derivative of nortropanol, has been evaluated in a number of clinical and pharmacological studies. Selected…”
Get full text

Future drugs for the treatment of benign prostatic hyperplasia by ANDERSSON, Karl-Erik, CHAPPLE, C. R, HÖFNER, K

“…For at least a decade, no new drug principles have been added to the therapeutic armamentarium for the treatment of lower urinary tract symptoms (LUTS)…”
Get full text

High energy thermotherapy in the treatment of benign prostatic hyperplasia: results of the European Benign Prostatic Hyperplasia Study Group by de la Rosette, J J, de Wildt, M J, Höfner, K, Carter, S S, Debruyne, F M, Tubaro, A

“…We documented the results of high energy transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia. We evaluated 116 patients…”
Get more information

alpha(1)-Blocker therapy in the nineties: focus on the disease by Höfner, K

“…Therapy for benign prostatic hyperplasia has evolved rapidly over the last decade, with the introduction in the early 1990s of new agents such as…”
Get full text

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation by Jonas, U., Höfner, K., Madersbacher, H., Holmdahl, T. H.

“…Tolterodine is a new competitive muscarinic receptor antagonist developed for the treatment of the unstable bladder. A total of 242 patients were enrolled in a…”
Get full text

A questionnaire‐based outcome analysis of the Stamey bladder neck suspension procedure for the treatment of urinary stress incontinence: the Hannover experience by KUCZYK, M. A, KLEIN, S, GRÜNEWALD, V, MACHTENS, S, DENIL, J, HÖFNER, K, WAGNER, T, JONAS, U

“…Objectives  To evaluate the long‐term continence rate, including subjective satisfaction and therapy‐associated morbidity, of patients undergoing Stamey…”
Get full text